Published in Eur J Dermatol on March 12, 2013
CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo. Sci Transl Med (2014) 1.50
Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo. J Invest Dermatol (2014) 1.03
Oxidative stress markers induced by hyperosmolarity in primary human corneal epithelial cells. PLoS One (2015) 0.92
Evaluation of total antioxidant status, total oxidant status and oxidative stress index in patients with alopecia areata. Int J Clin Exp Med (2014) 0.85
Oxidative stress and alopecia areata. J Med Life (2015) 0.78
Whole Transcriptome Analysis (RNA Sequencing) of Peripheral Blood Mononuclear Cells of Vitiligo Patients. Dermatopathology (Basel) (2014) 0.75
Inhibition of inflammatory and proliferative responses of human keratinocytes exposed to the sesquiterpene lactones dehydrocostuslactone and costunolide. PLoS One (2014) 0.75
Novel approaches to vitiligo treatment via modulation of mTOR and NF-κB pathways in human skin melanocytes. Int J Biol Sci (2017) 0.75
Adult Onset Vitiligo: Multivariate Analysis Suggests the Need for a Thyroid Screening. Biomed Res Int (2016) 0.75
New antioxidant sesquiterpenes from a culture broth of Coprinus echinosporus. J Antibiot (Tokyo) (2014) 0.75
The activity and tissue distribution of thioredoxin reductase in basal cell carcinoma. J Cancer Res Clin Oncol (2016) 0.75
Cell death: apoptosis versus necrosis (review). Int J Oncol (2002) 2.20
Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: the Women's Health Initiative. Cancer (2013) 2.14
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol (2008) 1.81
Alopecia areata: autoimmune basis of hair loss. Eur J Dermatol (2004) 1.18
Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts. J Am Acad Dermatol (2011) 1.04
Modeling the bound conformation of Pemphigus vulgaris-associated peptides to MHC Class II DR and DQ alleles. Immunome Res (2006) 1.04
Transcriptional profiling in alopecia areata defines immune and cell cycle control related genes within disease-specific signatures. Genomics (2010) 1.04
Genome-wide transcriptional profiling in human squamous cell carcinoma of the skin identifies unique tumor-associated signatures. J Dermatol (2006) 0.94
Clinical applications of DNA microarray analysis. J Exp Ther Oncol (2003) 0.93
Investigation of human keratinocyte cell adhesion using atomic force microscopy. Nanomedicine (2009) 0.92
Cutaneous lupus erythematosus: understanding of clinical features, genetic basis, and pathobiology of disease guides therapeutic strategies. Autoimmunity (2006) 0.92
Quantitative analysis of human keratinocyte cell elasticity using atomic force microscopy (AFM). IEEE Trans Nanobioscience (2011) 0.88
Cytokine networks in Pemphigus vulgaris: An integrated viewpoint. Autoimmunity (2012) 0.85
Epitope definition by proteomic similarity analysis: identification of the linear determinant of the anti-Dsg3 MAb 5H10. J Transl Med (2004) 0.85
BEID: database for sequence-structure-function information on antigen-antibody interactions. Bioinformation (2008) 0.83
The role of T cells in cutaneous autoimmune disease. Autoimmunity (2005) 0.82
Proteomic definition of a desmoglein linear determinant common to Pemphigus vulgaris and Pemphigus foliaceous. J Transl Med (2006) 0.81
Patterns of use of sunless tanning product alternatives to indoor tanning among female college students. Arch Dermatol (2012) 0.81
Prediction of desmoglein-3 peptides reveals multiple shared T-cell epitopes in HLA DR4- and DR6-associated pemphigus vulgaris. BMC Bioinformatics (2006) 0.81
Monoclonal and polyclonal humoral immune response to EC HER-2/NEU peptides with low similarity to the host's proteome. Int J Cancer (2002) 0.81
Using rituximab (anti-CD20 antibody) in a patient with paraneoplastic pemphigus. J Drugs Dermatol (2003) 0.81
Disease relevant HLA class II alleles isolated by genotypic, haplotypic, and sequence analysis in North American Caucasians with pemphigus vulgaris. Hum Immunol (2005) 0.80
T cell targeted immunotherapy for autoimmune disease. Autoimmunity (2005) 0.80
Integration of genome-wide transcriptional and genetic profiles provides insights into disease development and clinical heterogeneity in alopecia areata. Genomics (2011) 0.80
Alopecia areata: genetic complexity underlies clinical heterogeneity. Eur J Dermatol (2007) 0.80
NMR probing of in silico identification of anti-HPV16 E7 mAb linear peptide epitope. Peptides (2004) 0.78
Atomic force microscopy as nanorobot. Methods Mol Biol (2011) 0.78
Global transcriptional analysis of psoriatic skin and blood confirms known disease-associated pathways and highlights novel genomic "hot spots" for differentially expressed genes. Genomics (2012) 0.77
Molecular signatures of basal cell carcinoma susceptibility and pathogenesis: a genomic approach. Int J Oncol (2012) 0.77
Immunological hotspots analyzed by docking simulations: evidence for a general mechanism in pemphigus vulgaris pathology and transformation. BMC Immunol (2008) 0.77
T cell receptor Beta chain gene usage in endemic pemphigus foliaceus (fogo selvagem). J Invest Dermatol (2002) 0.77
Characterization of polyclonal antibodies raised against a linear peptide determinant of desmoglein-3. J Exp Ther Oncol (2005) 0.77
Role of MHC II affinity and molecular mimicry in defining anti-HER-2/neu MAb-3 linear peptide epitope. Peptides (2003) 0.77
HLA-E*0103X is associated with susceptibility to Pemphigus vulgaris. Exp Dermatol (2013) 0.77
Specific immunoglobulin isotypes correlate with disease activity, morphology, duration and HLA association in Pemphigus vulgaris. Autoimmunity (2012) 0.76
Bullous pemphigoid after herpes zoster vaccine administration: association or coincidence? J Drugs Dermatol (2011) 0.76
Gender differences in alopecia areata. J Drugs Dermatol (2014) 0.76
A globally available internet-based patient survey of pemphigus vulgaris: epidemiology and disease characteristics. Dermatol Clin (2011) 0.76
Preliminary data on Pemphigus vulgaris treatment by a proteomics-defined peptide: a case report. J Transl Med (2006) 0.75
Development of a disease registry for autoimmune bullous diseases: initial analysis of the pemphigus vulgaris subset. Acta Derm Venereol (2015) 0.75
A case of argyria: multiple forms of silver ingestion in a patient with comorbid schizoaffective disorder. Cutis (2012) 0.75
Lyme disease--part I: epidemiology and etiology. Cutis (2002) 0.75
Lyme disease--part II: clinical features and treatment. Cutis (2002) 0.75
Two men with toxic shock syndrome presenting with targetoid and spotty skin rashes. Acta Derm Venereol (2002) 0.75
Case and discussion of Lyme disease. J Drugs Dermatol (2003) 0.75
Bullous pemphigoid associated with renal cell carcinoma and invasive squamous cell carcinoma. J Drugs Dermatol (2012) 0.75
Nodules on the arm of a diabetic patient. Arch Dermatol (2003) 0.75
Gene therapy in cancer: the missing point. J Exp Ther Oncol (2005) 0.75
Longitudinal Tracking of Autoantibody Levels in a Pemphigus Vulgaris Patient: Support for a Role of Anti-Desmoglein 1 Autoantibodies as Predictors of Disease Progression. J Drugs Dermatol (2017) 0.75
Exploring the link between herpes viruses and pemphigus vulgaris: literature review and commentary. Eur J Dermatol (2012) 0.75
Gender-based variability in disease presentation in pemphigus vulgaris. J Drugs Dermatol (2014) 0.75
PTPN22 1858T is not a risk factor for North American pemphigus vulgaris. Exp Dermatol (2011) 0.75
Rituximab Use in Pediatric Dermatology. J Drugs Dermatol (2016) 0.75
Darier's disease: a commonly misdiagnosed cutaneous disorder. J Drugs Dermatol (2008) 0.75
Cancer prevention and therapy: strategies and problems. J Exp Ther Oncol (2003) 0.75
Evaluation of a Newly Available ELISA for Envoplakin Autoantibodies for the Diagnosis of Paraneoplastic Pemphigus. J Drugs Dermatol (2015) 0.75
Reproducible Novel Transcriptional Differences Between Psoriatic Lesional and Non-Lesional Skin Show Increased Inflammation and Metabolism. J Drugs Dermatol (2015) 0.75